SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
3bar
lightshipsailor
Thehammer
Thomas M.
To: skinowski who wrote (721672)7/17/2020 12:30:16 AM
From: frankw19004 Recommendations  Read Replies (1) of 793772
 

If they had more patients, maybe they’d get significant results - but, they say they couldn’t get more patients.

Because? The patients were not available? Or, to the point, the patients that matter - over 60 years old - were not available? I am skeptical because +60 cohorts are the majority of folk who pay attention to symptoms and are the majority who get ill from the infection and die from it.

As the poster notes, the graph below is not exactly 'scientific' but I'd note it sure as hell is empirical. MDs see graphs like this and they're going to check out the HCQ option, see it's mostly safe and cheap, stick the symptomatic patients on it while the [if available] test rigamarole and wait happens.



twitter.com

Except for immuno-compromised and old farts like us the Covid-19 thing is grinding to a halt, isn't it?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News